Expression of the cytolethal distending toxin in a geographically diverse collection of Haemophilus ducreyi clinical isolates

Sexually Transmitted Infections

Volumn 79, Issue 4, 2003, Pages 294-297

  Kulkarni, K ^a   Lewis, D A ^a,b   Ison, C A ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BACTERIAL TOXIN; CYTOLETHAL DISTENDING TOXIN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONTROLLED STUDY; CYTOTOXICITY; GENE AMPLIFICATION; GENE CLUSTER; GENITAL ULCER; GEOGRAPHIC DISTRIBUTION; HAEMOPHILUS DUCREYI; HELA CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; ULCUS MOLLE;

BACTERIAL TOXINS; CELL CYCLE PROTEINS; CHANCROID; DNA-BINDING PROTEINS; HAEMOPHILUS DUCREYI; HUMANS; IMMUNOBLOTTING; POLYMERASE CHAIN REACTION;

EID: 0042388389     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.79.4.294     Document Type: Article

References (35)

1. Lewis DA. Chancroid: from clinical practice to basic science. AIDS Patient Care and STDs 2000;14:19-36.
2. Brown TJ, Ballard RC, Ison CA. Specificity of the immune response to Haemophilus ducreyi. Microbiol Path 1995;19:31-8
3. Roggen EL, de Breucker S, van Dyck F, et al. Antigenic diversity in Haemophilus ducreyi as shown by western blot (immunoblot) analysis. Infect Immun 1992;60:590-5.
4. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999;75:3-17.
5. Palmer KL, Munson RS. Cloning and characterisation of the genes encoding the haemolysin of Haemophilus ducreyi. Mol Microbiol 1995;18;821-30.
6. Lewis DA, Stevens MK, Latimer JL, et al. Characterization of Haemophilus ducreyi cdtA, cdtB, and cdtC mutants in in vitro and in vivo systems. Infect Immun 2001;69:5626-34.
7. Cope LD, Lumbley S, Latimer JL, et al. A diffusible cytotoxin of Haemophilus ducreyi. Proc Natl Acad Sci USA 1997;94:4056-61.
8. Purvén M, Falsen F, Lagergård T. Cytotoxin production in 100 strains of Haemophilus ducreyi from different geographic locations. FEMS Microbiol Lett 1995;129:221-4.
9. Ahmed HJ, Svensson LA, Cope LD, et al. Prevalence of cdtABC genes encoding cytolethal distending toxin among Haemophilus ducreyi and Actinobacillus actinomycetemcomitans strains. J Med Microiol 2001;50:860-4.
10. Brown TJ, Ison CA. Non-radioactive ribotyping of Haemophilus ducreyi using a digoxigenin labelled cDNA probe. Epidemiol Infect 1993;110:289-95.
11. Brown TJ, Jardine J, Ison CA. Antibodies directed against Haemophilus ducreyi heat shock proteins. Microbiol Path 1993;15:131-9.
12. Hammond GW, Lian CJ, Wilt JC, et al. Antimicrobial susceptibility of Haemophilus ducreyi. Antimicrob Agents Chemother 1978;13:608-12.
13. Stevens MK, Porcella S, Klesney-Tait J, et al. A hemoglobin-binding outer membrane protein is involved in virulence expression by Haemophilus ducreyi in an animal model. Infect Immun 1996;64:1724-35.
14. Odumeru JA, Wiseman GM, Ronald AR. Role of lipopolysaccharide and complement in susceptibility of Haemophilus ducreyi to human serum. Infect Immun 1985;50:495-9.
15. Alfa MJ, Stevens MK, Degagne P, et al. Use of tissue culture and animal models to identify virulence-associated traits of Haemophilus ducreyi. Infect Immun 1995;63:1754-61.
16. Lewis DA, Klesney-Tait J, Lumbley SR, et al. Identification of the znuA-encoded periplasmic zinc transport protein of Haemophilus ducreyi. Infect Immun 1999;67:5060-8.
17. Stevens MK, Latimer JL, Lumbley SR, et al. Characterization of a Haemophilus ducreyi mutant deficient in the expression of the cytolethal distending toxin. Infect Immun 1999;67:3900-8.
18. Patrick CC, Kimura A, Jackson MA, et al. Antigenic characterization of the oligosaccharide portion of the lipooligosaccharide of nontypoble Haemophilus influenzae. Infect Immun 1987;55:2902-11.
19. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
20. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350-4.
21. Johnson WM, Lior H. A new heat-labile cytolethal distending toxin (CLDT) produced by Escherichia coli isolates from clinical material. Microbiol Path 1988;4:103-13.
22. Johnson WM, Lior H. Production of Shiga toxin and cytolethal distending toxin (CLDT) by serogroups of Shigella spp. FEMS Microbiol Letts 1987:235-8.
23. Johnson WM, Lior H. A new heat-labile cytolethal distending toxin (CLDT) produced by Campylobacter spp. Microbiol Path 1988;4:115-26.
24. Sugai M, Kawamoto T, Peres S, et al. The cell cycle-specific growth-inhibitory factor produced by Actinobacillus actinomycetemcomitans is a cytolethal distending toxin. Infect Immun 1998;66:5008-19.
25. Alfa MJ, DeGagne P. Attachment of Haemophilus ducreyi to human foreskin cells. 9th International Meeting ISSTDR, 6-9 October 1991, Banff, Alberta, Canada, 1991.
26. Alfa MJ. Cytopathic effect of Haemophilus ducreyi for human foreskin cell culture. J Med Microbiol 1992;37:43-50.
27. Cortes-Bratti X, Chaves-Olarte E, Lagergard T, et al. The cytolethal distending toxin from the chancroid bacterium Haemophilus ducreyi induces cell-cycle arrest in the G2 phase. J Clin Invest 1999;103:107-15.
28. Lagergård T, Purvén M, Frisk A. Evidence of Haemophilus ducreyi adherence to and cytotoxin destruction of human epithelial cells. Microbiol Path 1993;14:417-31.
29. Purvén M, Lagergård T. Haemophilus ducreyi, a cytotoxin-producing bacterium. Infect Immun 1992;60:1156-62.
30. Palmer KL, Thornton AC, Fortney KR, et al. Evaluation of an isogenic haemolysin-deficient mutant in the human model of Haemophilus ducreyi infection. J Infect Dis 1998;178:191-9.
31. Young RS, Fortney KR, Gelfanova V, et al. Expression of cytolethal distending toxin and hemolysin is not required for pustule formation by Haemophilus ducreyi in human volunteers. Infect Immun 2001;69:1938-42.
32. He J, Choe S, Walker R, et al. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J Virol 1995;69:6705-11.
33. Bartz SR., Rogel ME., Emerman M. Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control. J Virol 1996;70:2324-31.
34. Elwell CA, Dreyfus LA. DNase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest. Mol Microbiol 2000;37:952-63.
35. Gelfanova V, Hansen EJ, Spinola SM. Cytolethal distending toxin of Haemophilus ducreyi induces apoptotic death of jurkat T cells. Infect Immun 1999;67:6394-402.